Nodes Advisors AG Switzerland

We are a corporate finance firm committed to advancing the field of Healthcare through advisory,and investments.

We advise and buy-side and sell side corporates and Family offices on investment in Healthcare & life Sciences across Switzerland, Europe and the US.
Company Size (Fulltime employees)
Year of foundation
2018
Headquartner in China
Plan in China
We would like to partner with strong Chinese funds who are interested in incubating and investing in European and US early stage companies and facilitate market acess and technology integration in chinese market.
Eliott Harfouche
Partner 
Functionality

REM Analytics SA Switzerland

REM Analytics is a research and development service organisation, helping our customers develop and commercialise new products fast.
Having developed a series of core proprietary technologies, we deploy them to guarantee our customers the shortest time from concept to market. Our areas of focus are the development of personalised nutrition solutions, active food ingredients, functional cosmetics and agriculture.
Year of foundation
2020
Please specify your partnering goal
Identifying partners to jointly develop new products and services
Headquartner in China
Plan in China
Our goal is to identify innovation driven companies with whom to partner for joint development projects.
Assets Information 1: Name|Description|Indications|Stage|IP countries
ATGC|Microbniome analysis platform||Deployed and functioning|
Assets Information 2
ACIMA|Advanced Clinical data acquisition platform|Personalised medicine|Prototype test in progress|
Paulo Refinetti
Dr. 
Functionality

Wanbang Biopharmaceuticals (Group) Co., Ltd China

Wanbang Biopharmaceuticals (Wanbang Biopharma) is a core member of Shanghai Fosun PHARMACEUNCAL (group) Co., Ltd.(Fosun Pharma”, Stock code: 600196-SH,02196-HK).
Dr Di Simon
高级BD经理